Intervention

Fluticasone Propionate

ClinicalTrials.gov intervention label

Clinical trials14

Recruiting0

Common conditions15

Lead sponsors shown12

Clinical trials

14 shown

Novel Method for Removal of Orally Deposited Inhaled Fluticasone PropionateNCT07664527 · 2026-11-01

NOT_YET_RECRUITING

Personalized Treatment Algorithms for Difficult-to-treat AsthmaNCT04179461 · 2018-03-16

Study of Fluticasone Propionate Multidose Dry Powder Inhaler Compared With Fluticasone Propionate/Salmeterol Multidose Dry Powder InhalerNCT02980133 · 2016-12-28

Efficacy of Intermittent Tiotropium in Early Childhood WheezingNCT03199976 · 2016-04-20

The Use of Topical Nasal Steroids for Skin Reactions to Continuous Glucose Monitoring System, Among Children and Youth With Type 1 Diabetes Mellitus: Case SeriesNCT03594565 · 2016-03-01

A Dose-ranging Study of Fluticasone Furoate (FF)NCT01563029 · 2012-03-28

12-Week Study in Adult Subjects With AsthmaNCT01516073 · 2012-03-01

A Study To Determine Effects Of Fluticasone Propionate On Sputum Neutrophils After Inhaled Lipopolysaccharide Challenge In VolunteersNCT01364519 · 2011-07-01

Dose Response of Fractional Exhaled Nitric Oxide (FeNO) to Inhaled Steroids in Mild-to-moderate AsthmaNCT00995657 · 2009-10-01

Efficacy, Safety and Pharmacokinetics of QAV680 in Asthma PatientsNCT00814216 · 2008-12-01

The Effects of Montelukast on Smokers With AsthmaNCT00712335 · 2007-02-01

A Dose-Finding Study Evaluating Safety and Efficacy in Patients With Chronic Obstructive Pulmonary DiseaseNCT00403286 · 2006-11-01

Enhancement of in-Vitro GC Function in Patients With COPDNCT00241631 · 2006-04-01

A Study Measuring Asthma Control In Pediatric And Adolescent Subjects Whose Asthma Is Worsened By Activity Or ExerciseNCT00118716 · 2003-12-23

Common conditions

Asthma6 Activity/Exercise Induced Bronchospasm1 Asthma in Children1 Asthmatic Bronchitis1 Asthmatic Smokers1 Bronchospasm1 Chronic Obstructive Pulmonary Disease1 COPD1 Hypersensitivity1 Non-asthmatic Smokers1 Obstruction Airway1 Pulmonary Disease, Chronic Obstructive1 T1DM1 Wheezing1 Wheezy Bronchitis1

Leading sponsors

Dey2 GlaxoSmithKline2 Assaf-Harofeh Medical Center1 Children's Hospital Medical Center, Cincinnati1 Helsinki University Central Hospital1 Imperial College London1 Inje University1 Novartis1 Pfizer1 Teva Branded Pharmaceutical Products R&D, Inc.1 University of Dundee1 University of Wisconsin, Madison1

Trial status mix

COMPLETED12

NOT_YET_RECRUITING1

TERMINATED1

Phase mix

PHASE26

PHASE45

EARLY_PHASE11

PHASE11

PHASE31

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.